Lumida
/SMMT
⌘K
Summit Therapeutics Inc

Summit Therapeutics Inc

SMMT
$13.81USD+0.36%+0.05 today

MARKET CAP

10.7B

P/E (TTM)

FWD P/E

DAY RANGE

$13 – $14

52W RANGE

$13
$31

AI Summary

Stalk
Buy NowMedium

SMMT is in a Stage 2 Advancing (Corrective Reset) with higher lows/higher highs since mid-June. A Bullish Pivot Point has confirmed structural repair and shift toward upward mean-reversion. Price is tightly tracking rising 9EMA/20EMA, offering a favorable pullback entry into the EMA support zone. Medium-term bias remains bullish, supported by constructive volume and improving relative strength, while the primary risk is resistance at the 50-day SMA and potential distribution near overbought readings.

  • Phase III Harmony trial shows 34% reduction in death risk vs PD-1/chemo in NSCLC
  • Q4’25 cash of $713.4M with zero debt provides funding through key readouts
  • Weak profitability metrics highlight low returns amid high R&D spend
Full analysis →
Insider Trades25 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 12, 2026BuySMMTRobert W DugganCo-Chief Executive Officer3,810,000$13.12$10.7B-55.42%+10.04%$50.0M+0.67%Buy Now
Jun 12, 2026BuySMMTMahkam ZanganehCo-Chief Executive Officer3,810,000$13.12$10.7B-55.42%+10.04%$50.0M+0.67%Buy Now
Jun 4, 2026BuySMMTManmeet Singh SoniCOO and CFO50,000$14.45$10.7B-55.42%+10.04%$722.3K+0.81%Buy Now
Jun 4, 2026BuySMMTMahkam ZanganehCo-Chief Executive Officer100,000$14.60$10.7B-55.42%+10.04%$1.5M+0.39%Buy Now
Jun 4, 2026BuySMMTRobert W DugganCo-Chief Executive Officer100,000$14.60$10.7B-55.42%+10.04%$1.5M+0.39%Buy Now
Oct 21, 2025BuySMMTBhaskar AnandChief Accounting Officer26,680$18.74$10.7B-55.42%+10.04%$500.0K+20.05%Buy Now
Oct 21, 2025BuySMMTManmeet Singh SoniCOO and CFO53,361$18.74$10.7B-55.42%+10.04%$1.0M+1.77%Buy Now
Oct 21, 2025BuySMMTMahkam ZanganehCo-Chief Executive Officer14,274,277$18.74$10.7B-55.42%+10.04%$267.5M+2.45%Buy Now
Oct 21, 2025BuySMMTRobert W DugganCo-Chief Executive Officer14,274,277$18.74$10.7B-55.42%+10.04%$267.5M+2.45%Buy Now
Sep 10, 2025BuySMMTRobert W DugganCo-Chief Executive Officer338,394$17.69$10.7B-55.42%+10.04%$6.0M+0.03%Buy Now
Sep 10, 2025BuySMMTMahkam ZanganehCo-Chief Executive Officer338,394$17.69$10.7B-55.42%+10.04%$6.0M+0.03%Buy Now
May 30, 2025BuySMMTRobert W DugganCo-Chief Executive Officer74,545$2.64$10.7B-55.42%+10.04%$196.8K+0.01%Buy Now
May 30, 2025BuySMMTMahkam ZanganehCo-Chief Executive Officer74,545$2.64$10.7B-55.42%+10.04%$196.8K+0.01%Buy Now
Apr 8, 2025BuySMMTRobert W DugganCo-Chief Executive Officer3,985,055$1.58$10.7B-55.42%+10.04%$6.3M+0.72%Buy Now
Apr 8, 2025BuySMMTMahkam ZanganehCo-Chief Executive Officer3,985,055$1.58$10.7B-55.42%+10.04%$6.3M+0.72%Buy Now
Oct 3, 2024BuySMMTMahkam ZanganehCo-Chief Executive Officer315,681$1.58$10.7B-55.42%+10.04%$498.8K+3.19%Buy Now
Sep 11, 2024BuySMMTBhaskar AnandChief Accounting Officer22,026$22.70$10.7B-55.42%+10.04%$500.0K+20.13%Buy Now
Sep 11, 2024BuySMMTManmeet Singh SoniCOO and CFO44,052$22.70$10.7B-55.42%+10.04%$1.0M+1.48%Buy Now
Sep 11, 2024BuySMMTMahkam ZanganehCo-Chief Executive Officer44,052$22.70$10.7B-55.42%+10.04%$1.0M+0.18%Buy Now
Sep 11, 2024BuySMMTRobert W DugganCo-Chief Executive Officer3,325,991$22.70$10.7B-55.42%+10.04%$75.5M+0.61%Buy Now
Mar 27, 2024BuySMMTMahkam ZanganehChief Executive Officer110,321$3.73$10.7B-55.42%+10.04%$411.1K+0.43%Buy Now
Mar 26, 2024BuySMMTAnkur DhingraChief Financial Officer100,000$3.75$10.7B-55.42%+10.04%$375.0K+39.22%Buy Now
Dec 13, 2023BuySMMTAnkur DhingraChief Financial Officer20,400$2.17$10.7B-55.42%+10.04%$44.3K+4.34%Buy Now
Dec 11, 2023BuySMMTMahkam ZanganehChief Executive Officer810,495$1.50$10.7B-55.42%+10.04%$1.2M+3.23%Buy Now
Oct 13, 2023BuySMMTManmeet Singh SoniChief Operating Officer2,976,190$1.68$10.7B-55.42%+10.04%$5.0M+21.26%Buy Now